Literature DB >> 7851378

Activin A and retinoic acid synergize in cyclooxygenase-1 and thromboxane synthase induction during differentiation of J774.1 macrophages.

R M Nüsing1, S Mohr, V Ullrich.   

Abstract

The murine macrophage cell line J774.1 was used to study the development of prostanoid biosynthesis under the influence of activin A and retinoic acid. Treatment of cells with 3 nM activin A for 48 h increased the biosynthesis of the prostaglandins E2, D2, F2 alpha and thromboxane A2 more than fourfold due to an induction of cyclooxygenase-1 while cyclooxygenase-2 was unaffected. Transforming growth factor-beta acted in a similar way. Retinoic acid, when present alone, was without effect on the total cyclooxygenase products and only slightly changed the pattern of prostanoids. However, when coincubated with activin A, retinoic acid specifically induced the synthesis of thromboxane-A-synthase-specific mRNA and induced an increase in enzyme activity with a synergistic effect on cyclooxygenase-1 protein and mRNA. JunB, but not c-jun, mRNA expression was found under these conditions in addition to a transient c-fos mRNA increase. The combination of activin A and retinoid acid may be regarded as a differentiation model to study the development of cell-specific prostanoid patterns in macrophages and possibly other differentiating cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851378     DOI: 10.1111/j.1432-1033.1995.tb20368.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Activin A: a potential therapeutic target for characterizing and stopping joint pain early in rheumatoid arthritis patients.

Authors:  Fei Dong; Xijing He
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 2.  Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.

Authors:  Barbara Jung; Jonas J Staudacher; Daniel Beauchamp
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

3.  Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A.

Authors:  R M Nüsing; J Barsig
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. I. Effects after oral administration.

Authors:  E A Romero-Sandoval; C Molina; M Alique; V Moreno-Manzano; F J Lucio; J F Herrero
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

5.  Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. II. Effects after intrathecal administration.

Authors:  M Alique; F J Lucio; J F Herrero
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

6.  Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells.

Authors:  R M Nüsing; T Klein; J Pfeilschifter; V Ullrich
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

7.  Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study.

Authors:  David Morritz de Kretser; Jonathan Guy Bensley; Ville Pettilä; Rita Linko; Mark Peter Hedger; Susan Hayward; Carolyn Anne Allan; Robert Ian McLachlan; Helen Ludlow; David James Phillips
Journal:  Crit Care       Date:  2013-10-31       Impact factor: 9.097

8.  Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo.

Authors:  Sandy Stayte; Peggy Rentsch; Anna R Tröscher; Maximilian Bamberger; Kong M Li; Bryce Vissel
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

Review 9.  Activin, neutrophils, and inflammation: just coincidence?

Authors:  Paschalis Sideras; Eirini Apostolou; Athanasios Stavropoulos; Alexandros Sountoulidis; Arianna Gavriil; Anastasia Apostolidou; Evangelos Andreakos
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.